GTR 114199987

Bids Are Invited For Acquisition Of Medicines

ICB — International Competitive Bid Closed South America
Tender Information
GTR Reference
114199987
Tendering Authority
Subscribe to view
Tender No
44/2026
Financer Name
Self-Funded
Work Title
Bids Are Invited For Acquisition Of Medicines
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
15-06-2026 Closed
Work Detail
Dipyrone Sodium Dosage: 500, Presentation: Injectable Solution, Paracetamol Tablet Dosage: 500, Nimesulide Dosage: 100 Mg, Adenosine Dosage: 3, Indication: Injectable Solution, Distilled Water Physical Appearance: Colorless, Odorless, Tasteless Liquid, Additional Characteristics: According To The Brazilian Pharmacopoeia, Amiodarone Dosage: 50Mg/Ml, Indication: Injectable, Amoxicillin Active Ingredient: Associated With Potassium Clavulanate, Concentration: 500Mg + 125Mg, Atropine Sulfate Dosage: 0. 25, Use: Injectable Solution, Benzylpenicillin Presentation: Benzathine, Dosage: 1,200,000Ui, Use: Injectable, Sodium Bicarbonate Dosage: 8.4%, Sodium Bicarbonate Concentration: 8.40%, Pharmaceutical Form: Injectable Solution, Additional Feature: In Closed System, Vecuronium Bromide Dosage: 4, Captopril Concentration: 25, Cephalexin Dosage: 500, Ceftriaxone Sodium Concentration: 1, Pharmaceutical Form: Powder For Injectable Solution, Ketoprofen Concentration: 100, Pharmaceutical Form: Lyophilic Powder For Injection, Potassium Chloride Dosage: 10%, Sodium Chloride Active Ingredient: 0.9%_ Injectable Solution, Application: Closed System, Sodium Chloride Dosage: 20%, Suxamethonium Chloride Dosage: 100, Dexmedetomidine Hydrochloride Concentration: 100, Pharmaceutical Form: Injectable Solution, Lidocaine Hydrochloride Dosage: 2%, Presentation: Injectable, Metoclopramide Hydrochloride Dosage: 5 Mg/Ml, Metoclopramide Hydrochloride Dosage: 10 Mg, Clotrimazole Dosage: 10, Use: Cream, Deslanoside Dosage: 0.2 Mg/Ml, Dexamethasone Dosage: 0.1%, Presentation: Cream, Dexamethasone Dosage: 4, Diclofenac Presentation: Potassium Salt, Dosage: 50 Mg, Diclofenac Presentation: Sodium Salt, Dosage: 25Mg/Ml, Orphenadrine Citrate Composition: Associated With Dipyrone E Caffeine, Dosage: 35Mg + 300Mg + 50Mg, Dobutamine Hydrochloride Dosage: 12.5, Dopamine Dosage: 5 Mg/Ml, Epinephrine Dosage: 1Mg/Ml, Fluconazole Dosage: 150, Furosemide Composition: 10 Mg/Ml, Gentamicin Dosage: 40, Application: Injectable Solution, Glucose Concentration: 25%, Glucose Concentration: 5%, Additional Feature: Closed System, Pvc-Free Primary Packaging, Hydrochlorothiazide Dosage: 50, Scopolamine Butylbromide Presentation: Associated With Sodium Dipyrone, Dosage: 4Mg + 500Mg/Ml, Insulin Type: Aspart, Composition: With Nicotinamide (Vit B3), Concentration: 100, Additional: With Application System, Insulin Type: Glargine, Additional Characteristic: Refill, Presentation: Jelly, Mannitol Dosage: 20%, Additional Characteristics: Closed System, Midazolam Dosage: 5, Application: Injectable, Isosorbide Active Ingredient: Salt Mononitrate, Dosage: 20, Neomycin Composition: Associated With Bacitracin, Concentration: 5Mg + 250Ui/G, Medication Type: Ointment, Norepinephrine Concentration: 2, Petrolatum Physical Aspect: Liquid, Type: Laxative, Use: Oral, Omeprazole Concentration: 40, Paracetamol Presentation: Associated With Codeine, Dosage: 500Mg + 30Mg, Promethazine Hydrochloride Dosage: 25, Ringers Composition: Associated With Sodium Lactate, Additional Feature: Closed System, Ropivacaine Hydrochloride Dosage: 0.2%, Simethicone Concentration: 75, Pharmaceutical Form: Oral Solution - Drops, Chlorhexidine Digluconate Dosage: 0. 5%, Application: Alcoholic Solution, Chlorhexidine Digluconate Dosage: 4%, Application: Degerming Agent, Hydrocortisone Composition: Sodium Succinate Salt, Concentration: 500, Pharmaceutical Form: Lyophilic Powder For Injection, Morphine Presentation: Sulfate, Concentration: 10Mg/Ml, Polymyxin B Dosage: 500,000Ui, Tobramycin Dosage: 0.3%, Apres
Key Value
Tender Value
12,281 - BRL
Tender Documents
Global Tender Document
3556f62c-c5b9-446c-a65e-a428bc732961.html
Attachments
Additional Details Available on Click
  • Tendering Authority
  • Publication Document (Tender Document / Tender Notice)
Disclaimer

We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.

Tell us about your Product / Services,

We will Find Tenders for you

TenderDetail
Loading tenders